Published in Am J Addict on September 20, 2013
Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev (2013) 1.33
Testosterone enhances risk tolerance without altering motor impulsivity in male rats. Psychoneuroendocrinology (2013) 0.91
Anabolic-androgenic Steroid use and Psychopathology in Athletes. A Systematic Review. Curr Neuropharmacol (2015) 0.82
Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem. Addiction (2015) 0.82
Anabolic-androgenic steroids and decision making: Probability and effort discounting in male rats. Psychoneuroendocrinology (2015) 0.81
Ruptured Tendons in Anabolic-Androgenic Steroid Users: A Cross-Sectional Cohort Study. Am J Sports Med (2015) 0.80
Synthetic Androgens as Designer Supplements. Curr Neuropharmacol (2015) 0.80
Anabolic-androgenic steroids decrease dendritic spine density in the nucleus accumbens of male rats. Neuroscience (2016) 0.79
Anabolic-androgenic steroids and appetitive sexual behavior in male rats. Horm Behav (2014) 0.79
Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors. Psychopharmacology (Berl) (2016) 0.76
Sex and exercise interact to alter the expression of anabolic androgenic steroid-induced anxiety-like behaviors in the mouse. Horm Behav (2014) 0.76
The aetiology and trajectory of anabolic-androgenic steroid use initiation: a systematic review and synthesis of qualitative research. Subst Abuse Treat Prev Policy (2014) 0.76
Brain connectivity aberrations in anabolic-androgenic steroid users. Neuroimage Clin (2016) 0.75
White matter abnormalities in long-term anabolic-androgenic steroid users: A pilot study. Psychiatry Res (2016) 0.75
Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use. Circulation (2017) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet (2012) 6.36
Anabolic-androgenic steroid dependence: an emerging disorder. Addiction (2009) 2.03
Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence. Am J Psychiatry (2009) 1.72
Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc (2006) 1.68
Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend (2008) 1.65
Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch Gen Psychiatry (1994) 1.64
Anabolic steroid use in weightlifters and bodybuilders: an internet survey of drug utilization. Clin J Sport Med (2005) 1.49
Trends in non-medical use of anabolic steroids by U.S. college students: results from four national surveys. Drug Alcohol Depend (2007) 1.40
Illicit anabolic-androgenic steroid use. Horm Behav (2009) 1.35
Symptoms and correlates of anabolic-androgenic steroid dependence. Br J Addict (1991) 1.33
Anabolic steroid users' attitudes towards physicians. Addiction (2004) 1.30
Evolving ideals of male body image as seen through action toys. Int J Eat Disord (1999) 1.25
Anabolic steroids: a review for the clinician. Sports Med (2002) 1.22
Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychother Psychosom (2000) 1.20
Anabolic steroid abuse among teenage girls: an illusory problem? Drug Alcohol Depend (2006) 1.18
Over-the-counter drug use in gymnasiums: an underrecognized substance abuse problem? Psychother Psychosom (2001) 1.15
Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem? J Clin Psychiatry (2003) 1.11
A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. J Int Soc Sports Nutr (2007) 1.07
The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training. Pharmacotherapy (2011) 1.07
Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med (2000) 1.04
Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users. Clin J Sport Med (1995) 1.02
Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study. Biol Psychiatry (2011) 1.01
Anabolic-androgenic steroid use disorders among a sample of Australian competitive and recreational users. Drug Alcohol Depend (2000) 0.97
A study of 100 anabolic-androgenic steroid users. Med J Aust (1998) 0.96
The diagnostic dilemma of pathological appearance and performance enhancing drug use. Drug Alcohol Depend (2010) 0.91
Illicit use of androgens and other hormones: recent advances. Curr Opin Endocrinol Diabetes Obes (2012) 0.86
Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs. Drug Alcohol Rev (2008) 0.86
Anabolic androgenic steroids--use and correlates among gym users--an assessment study using questionnaires and observations at gyms in the Stockholm region. Int J Environ Res Public Health (2011) 0.85
Cognitive deficits in long-term anabolic-androgenic steroid users. Drug Alcohol Depend (2012) 0.85
Psychological and physical impact of anabolic-androgenic steroid dependence. Pharmacotherapy (2012) 0.84
Culture, psychosomatics and substance abuse: the example of body image drugs. Psychother Psychosom (2012) 0.80
Women and anabolic steroids: an analysis of a dozen users. Clin J Sport Med (2010) 0.79
Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs. Addiction (2011) 3.42
Is dissociative amnesia a culture-bound syndrome? Findings from a survey of historical literature. Psychol Med (2006) 2.70
Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend (2003) 2.68
Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease. Ann Emerg Med (2006) 2.57
Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol (2005) 2.34
A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med (2002) 2.34
Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail (2010) 2.32
The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys. Biol Psychiatry (2013) 2.31
Family study of fibromyalgia. Arthritis Rheum (2004) 2.22
Tracking scientific interest in the dissociative disorders: a study of scientific publication output 1984-2003. Psychother Psychosom (2006) 2.14
Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications. J Am Coll Cardiol (2010) 2.06
Anabolic-androgenic steroid dependence: an emerging disorder. Addiction (2009) 2.03
Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study. Am J Psychiatry (2007) 2.01
Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence. Am J Psychiatry (2009) 1.72
The subsyndromal phenomenology of borderline personality disorder: a 10-year follow-up study. Am J Psychiatry (2007) 1.71
Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend (2008) 1.65
Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend (2004) 1.61
Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry (2006) 1.61
Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum (2007) 1.61
Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry (2003) 1.55
Co-occurrence of binge eating disorder with psychiatric and medical disorders. J Clin Psychiatry (2008) 1.50
Binge eating disorder: a stable syndrome. Am J Psychiatry (2006) 1.49
Be prepared--the Boston Marathon and mass-casualty events. N Engl J Med (2013) 1.47
Sustained attention, visual processing speed, and IQ in children and adolescents with Schizophrenia Spectrum disorder and Psychosis Not Otherwise Specified. Percept Mot Skills (2005) 1.43
Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. Biol Psychiatry (2007) 1.42
Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial. J Sex Marital Ther (2011) 1.41
Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology (2009) 1.36
Illicit anabolic-androgenic steroid use. Horm Behav (2009) 1.35
Anabolic steroid users' attitudes towards physicians. Addiction (2004) 1.30
Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study. Drug Alcohol Depend (2003) 1.25
Images in cardiovascular medicine. Acute reversible stress-induced cardiomyopathy associated with cesarean delivery under spinal anesthesia. Circulation (2008) 1.23
Family studies of borderline personality disorder: a review. Harv Rev Psychiatry (2003) 1.23
Cognitive measures in long-term cannabis users. J Clin Pharmacol (2002) 1.23
Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry (2003) 1.22
Body image and attitudes toward male roles in anabolic-androgenic steroid users. Am J Psychiatry (2006) 1.20
Anabolic steroid abuse among teenage girls: an illusory problem? Drug Alcohol Depend (2006) 1.18
Familiality and heritability of binge eating disorder: results of a case-control family study and a twin study. Int J Eat Disord (2008) 1.17
Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications. Drug Alcohol Depend (2010) 1.09
Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial. J Clin Psychiatry (2006) 1.07
Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers. Drug Alcohol Depend (2009) 1.04
Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature. Am J Psychiatry (2010) 1.03
Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study. Biol Psychiatry (2011) 1.01
Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial. J Clin Psychiatry (2007) 1.01
Borderline psychopathology in the first-degree relatives of borderline and axis II comparison probands. J Pers Disord (2004) 1.00
Pharmacologic treatment of binge eating disorder. Int J Eat Disord (2003) 1.00
Topiramate in the long-term treatment of binge-eating disorder associated with obesity. J Clin Psychiatry (2004) 0.99
Family history study of the familial coaggregation of borderline personality disorder with axis I and nonborderline dramatic cluster axis II disorders. J Pers Disord (2009) 0.99
Role of antiepileptic drugs in the management of eating disorders. CNS Drugs (2009) 0.98
A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder. J Clin Psychiatry (2002) 0.96
Family study of borderline personality disorder and its sectors of psychopathology. Arch Gen Psychiatry (2011) 0.95
Human growth hormone abuse in male weightlifters. Am J Addict (2010) 0.95
Is PTSD caused by traumatic stress? J Anxiety Disord (2006) 0.95
Development of responder definitions for fibromyalgia clinical trials. Arthritis Rheum (2012) 0.93
Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial. Int J Eat Disord (2011) 0.92
Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial. J Clin Psychiatry (2003) 0.92
Acamprosate in the treatment of binge eating disorder: a placebo-controlled trial. Int J Eat Disord (2011) 0.92
Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment. J Clin Psychopharmacol (2010) 0.92
A diagnostic interview module for anabolic-androgenic steroid dependence: preliminary evidence of reliability and validity. Exp Clin Psychopharmacol (2010) 0.90
High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial. Hum Psychopharmacol (2008) 0.90
Neurophysiology of motor function following cannabis discontinuation in chronic cannabis smokers: an fMRI study. Drug Alcohol Depend (2004) 0.89
Memantine in the treatment of binge eating disorder: an open-label, prospective trial. Int J Eat Disord (2008) 0.89
Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial. Int Clin Psychopharmacol (2009) 0.88
Cannabis and motor function: fMRI changes following 28 days of discontinuation. Exp Clin Psychopharmacol (2008) 0.87
Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial. J Clin Psychiatry (2004) 0.87
Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study. Hum Psychopharmacol (2009) 0.87
Performance-enhancing drugs on the web: a growing public-health issue. Am J Addict (2013) 0.85
Estimating disease prevalence using relatives of case and control probands. Biometrics (2009) 0.85
A cardiopulmonary study of lisdexamfetamine in adults with attention-deficit/hyperactivity disorder. World J Biol Psychiatry (2012) 0.85
Cognitive deficits in long-term anabolic-androgenic steroid users. Drug Alcohol Depend (2012) 0.85
Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem. Addiction (2015) 0.82
Combination of D-dimer and amino-terminal pro-B-type natriuretic Peptide testing for the evaluation of dyspneic patients with and without acute pulmonary embolism. Arch Pathol Lab Med (2006) 0.82
Placebo response in binge eating disorder. Int J Eat Disord (2007) 0.81
Outcomes of surgical management of total HIP replacement in patients aged 65 years and older: cemented versus cementless femoral components and lateral or anterolateral versus posterior anatomical approach. J Orthop Res (2002) 0.81
Binge eating disorder: the next generation of research. Int J Eat Disord (2013) 0.80
Culture, psychosomatics and substance abuse: the example of body image drugs. Psychother Psychosom (2012) 0.80
Psychological and cognitive effects of long-term peyote use among Native Americans. Biol Psychiatry (2005) 0.80
Sodium oxybate in the treatment of binge eating disorder: an open-label, prospective study. Int J Eat Disord (2011) 0.79
Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder. Clin J Pain (2009) 0.79
A placebo-controlled trial of acetyl-L-carnitine and α-lipoic acid in the treatment of bipolar depression. J Clin Psychopharmacol (2013) 0.78
The effects of smoked nicotine on measures of subjective States and hypothalamic-pituitary-adrenal axis hormones in women during the follicular and luteal phases of the menstrual cycle. J Addict Med (2015) 0.77
National Athletic Trainers' Association position statement: anabolic-androgenic steroids. J Athl Train (2012) 0.77
Childhood body-focused behaviors and social behaviors as risk factors of eating disorders. Psychother Psychosom (2005) 0.77
Body fat perception in eating-disordered men. Int J Eat Disord (2004) 0.77
Anabolic androgenic steroid induced myocardial toxicity: an evolving problem in an ageing population. BMJ Case Rep (2011) 0.75
The missing left atrial appendage. J Cardiovasc Comput Tomogr (2011) 0.75
Anti-Social Behaviors Associated with Anabolic-Androgenic Steroid Use among Male Adolescents. Eur Addict Res (2015) 0.75
Hypothyroid dependent myocardial angiotensin receptor trafficking is involved in improved cardiac performance after heat acclimation. Life Sci (2010) 0.75
Thick hearts, high stakes, great uncertainties: screening athletes for hypertrophic cardiomyopathy. Heart (2008) 0.75